Step by Step Progress Towards Genetic Knowledge of Prostate Cancer


avatar Fernando Augusto de Lima Marson 1 , * , avatar Jose Dirceu Ribeiro 2 , avatar Carmen Silvia Bertuzzo 1

Department of Medical Genetics, Faculty of Medical Sciences, State University of Campinas (Unicamp), Campinas, São Paulo, Brazil
Department of Pediatrics, Faculty of Medical Sciences, State University of Campinas (Unicamp), Campinas, São Paulo, Brazil

how to cite: de Lima Marson F A, Ribeiro J D, Bertuzzo C S. Step by Step Progress Towards Genetic Knowledge of Prostate Cancer. Gene Cell Tissue. 2015;2(1):e24759.



  • 1.

    Perry AM, Attar EC. New insights in AML biology from genomic analysis. Semin Hematol. 2014;51(4):282-97. [PubMed ID: 25311741].

  • 2.

    Graubert T, Stone R. AML genomics for the clinician. Semin Hematol. 2014;51(4):322-9. [PubMed ID: 25311744].

  • 3.

    Cassese A, Guindani M, Vannucci M. A bayesian integrative model for genetical genomics with spatially informed variable selection. Cancer Inform. 2014;13(Suppl 2):29-37. [PubMed ID: 25288877].

  • 4.

    Lee KF, Weng JT, Hsu PW, Chi YH, Chen CK, Liu IY, et al. Gene expression profiling of biological pathway alterations by radiation exposure. Biomed Res Int. 2014;2014:834087. [PubMed ID: 25276823].

  • 5.

    Hoang LN, McConechy MK, Meng B, McIntyre JB, Ewanowich C, Blake Gilks C, et al. Targeted mutation analysis of endometrial clear cell carcinoma. Histopathology. 2014. [PubMed ID: 25308272].

  • 6.

    Seidabadi A, Rezatofighi SE, Motamedi H, Rashidi I. R462Q Mutation in Prostate Cancer Specimens. Gene Cell Tissue. 2014;1(2).

  • 7.

    Lin E, Chien J, Ong FS, Fan JB. Challenges and opportunities for next-generation sequencing in companion diagnostics. Expert Rev Mol Diagn. 2014:1-17. [PubMed ID: 25249308].

  • 8.

    Lohmann K, Klein C. Next generation sequencing and the future of genetic diagnosis. Neurotherapeutics. 2014;11(4):699-707. [PubMed ID: 25052068].

  • 9.

    Stasiewicz D, Staroslawska E, Brzozowska A, Mocarska A, Losicki M, Szumilo J, et al. [Epidemiology and risk factors of the prostate cancer]. Pol Merkur Lekarski. 2012;33(195):163-7. [PubMed ID: 23157136].

  • 10.

    Demichelis F, Stanford JL. Genetic predisposition to prostate cancer: Update and future perspectives. Urol Oncol. 2014. [PubMed ID: 24996773].

  • 11.

    Karyadi DM, Zhao S, He Q, McIntosh L, Wright JL, Ostrander EA, et al. Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families. Int J Cancer. 2014. [PubMed ID: 25273821].

  • 12.

    San Francisco IF, Rojas PA, Torres-Estay V, Smalley S, Cerda-Infante J, Montecinos VP, et al. Association of RNASEL and 8q24 variants with the presence and aggressiveness of hereditary and sporadic prostate cancer in a Hispanic population. J Cell Mol Med. 2014;18(1):125-33. [PubMed ID: 24224612].

  • 13.

    Alvarez-Cubero MJ, Saiz M, Martinez-Gonzalez LJ, Alvarez JC, Lorente JA, Cozar JM. [RNASEL study of genetics of prostate cancer and its relation to clinical staging]. Actas Urol Esp. 2012;36(5):306-11. [PubMed ID: 22464196].

  • 14.

    Li SX, Barrett BS, Harper MS, Heilman KJ, Halemano K, Steele AK, et al. Ribonuclease L is not critical for innate restriction and adaptive immunity against Friend retrovirus infection. Virology. 2013;443(1):134-42. [PubMed ID: 23725696].

  • 15.

    Jin W, Wu DD, Zhang X, Irwin DM, Zhang YP. Positive selection on the gene RNASEL: correlation between patterns of evolution and function. Mol Biol Evol. 2012;29(10):3161-8. [PubMed ID: 22513284].

  • 16.

    Shkedi-Rafid S, Dheensa S, Crawford G, Fenwick A, Lucassen A. Defining and managing incidental findings in genetic and genomic practice. J Med Genet. 2014;51(11):715-23. [PubMed ID: 25228303].

  • 17.

    Zhao J, Zhu Y, Boerwinkle E, Xiong M. Pathway analysis with next-generation sequencing data. Eur J Hum Genet. 2014. [PubMed ID: 24986826].